Sientra (NASDAQ:SIEN) Trading Down 5.4%
Sientra Inc (NASDAQ:SIEN) fell 5.4% during mid-day trading on Friday . The stock traded as low as $8.03 and last traded at $8.07, 901,400 shares were traded during mid-day trading. An increase of 5% from the average session volume of 861,663 shares. The stock had previously closed at $8.53.
Several research firms recently issued reports on SIEN. Stephens set a $16.00 price target on shares of Sientra and gave the company a “buy” rating in a research report on Friday, August 9th. William Blair raised shares of Sientra from a “market perform” rating to an “outperform” rating in a research report on Tuesday, November 5th. BidaskClub raised shares of Sientra from a “sell” rating to a “hold” rating in a research report on Thursday, October 10th. Canaccord Genuity set a $13.00 price objective on shares of Sientra and gave the stock a “buy” rating in a report on Tuesday, September 24th. Finally, Maxim Group reaffirmed a “buy” rating and set a $12.00 price objective (down from $16.00) on shares of Sientra in a report on Friday, August 9th. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Sientra presently has an average rating of “Buy” and an average price target of $15.11.
The stock’s fifty day simple moving average is $6.74 and its 200-day simple moving average is $6.62. The stock has a market capitalization of $422.08 million, a PE ratio of -2.48 and a beta of 0.24. The company has a current ratio of 2.80, a quick ratio of 2.32 and a debt-to-equity ratio of 0.40.
Several institutional investors and hedge funds have recently made changes to their positions in SIEN. Schroder Investment Management Group bought a new stake in shares of Sientra during the second quarter valued at about $7,700,000. UBS Group AG increased its position in shares of Sientra by 37.9% during the second quarter. UBS Group AG now owns 2,657,863 shares of the medical instruments supplier’s stock valued at $16,372,000 after buying an additional 730,475 shares during the period. Vanguard Group Inc. increased its position in shares of Sientra by 64.4% during the second quarter. Vanguard Group Inc. now owns 1,857,953 shares of the medical instruments supplier’s stock valued at $11,445,000 after buying an additional 727,906 shares during the period. Marshall Wace LLP increased its position in shares of Sientra by 6,998.6% during the second quarter. Marshall Wace LLP now owns 710,142 shares of the medical instruments supplier’s stock valued at $4,375,000 after buying an additional 700,138 shares during the period. Finally, Citadel Advisors LLC increased its position in shares of Sientra by 421.7% during the second quarter. Citadel Advisors LLC now owns 450,910 shares of the medical instruments supplier’s stock valued at $2,778,000 after buying an additional 364,473 shares during the period. Hedge funds and other institutional investors own 88.41% of the company’s stock.
Sientra Company Profile (NASDAQ:SIEN)
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Featured Story: What is the Book Value of a Share?
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.